Professor David Mant, Emeritus Professor of General Practice and Emeritus Fellow of Kellogg College, is made an OBE for services to medicine in the New Year’s Honours List. Professor Mant is a member of the Oxford Biomedical Research Centre’s Strategic Partnership Board. See full press release.
The Cochrane Dementia and Cognitive Improvement Group, based at the JR Hospital, is running a volunteer recruitment campaign in conjunction with the development of a free online course “Making Sense of the Evidence in Dementia”, primarily aimed at caregivers and former caregivers of people with dementia. It is a year’s Cochrane-NHS Engagement feasibility project funded … Read more
Last December, Kevin Jones, a 43-year-old businessman from Dorset was diagnosed with pancreatic cancer. It was advanced and inoperable. Today, as he prepares to celebrate Christmas with his son, Mr Jones is free from any detectable trace of the disease; the human face of a medical breakthrough so exciting that the scientists involved struggle to … Read more
Taking a low-dose aspirin every day will reduce your chances of dying from cancer, scientists say today, confirming the over-the-counter pill as the most extraordinary drug yet discovered. Daily aspirin has already been shown to cut the chances of heart attacks and stroke in people who are at risk. The study published today in the … Read more
A Daily Mail article (23.11.10) features the country’s top heart doctors, as recommended by their peers. Two of the best doctors (Adrian Banning and Bernard Prendergast) come from Oxford, read more.
A new retinal implant technique is being trialled at the Oxford Eye Hospital in 2011 for the first time in the UK. Professor Robert MacLaren, Consultant Retinal Surgeon at the Oxford Eye Hospital, is leading a trial to look at new technology that aims to restore sight to blind patients. By implanting a device underneath … Read more
Professor Peter Rothwell, of the John Radcliffe Hospital, Oxford, and Oxford University, describes the findings of a recent study, tipping the balance in favour of regular aspirin use. http://www.bbc.co.uk/news/health-11597163 http://www.guardian.co.uk/society/2010/oct/22/aspirin-reduce-bowel-cancer-risk
The Research Services Medical Sciences team has organised a training session/masterclass on the implications of the Human Tissue Act (2004) for research. Date: Thursday 18 November 3.30-5pm All places now filled Location: Meeting Room, Grey Institute for Radiation Oncology & Biology, Old Road Campus Research Building Although the session is aimed at research administration staff, it is … Read more
Researchers at Immunocore Limited today announced that IMCgp100, a targeted therapeutic for the treatment of advanced metastatic melanoma, has received regulatory and ethics approval and has opened enrolment for clinical trials in the England and USA. IMCgp100 is the first clinical candidate originating from Immunocore’s innovative ImmTAC technology platform and a new treatment could benefit … Read more
OxBRC Ethics Fellow, Dr Mark Sheehan has been appointed to the panel of the Advisory Group for National Specialised Services (AGNSS). This committee advises health Ministers on which services should be nationally commissioned and the centres that should provide them. About 60 highly specialised services are commissioned nationally by NHS Specialised Services. The Advisory Group for National Specialised Services … Read more
Dr Paresh Vyas, Blood Theme research leader has co-authored a book which has won the BMA Medical Book Awards 2010 first prize for internal medicine. The award was presented to A. Victor Hoffbrand for ‘Color Atlas of Clinical Hematology’.
With dementia affecting 750,000 people in the UK it has become a topic of great interest receiving recognition in government strategies, media campaigns and new research. Dementia is becoming more common and many of our lives are affected by the condition; 25 million people in the UK know a close friend, a family member or … Read more
Oxford Biomedical Research Centre – Public Talks 2010/2011 Subject & Speaker Date Venue Comments Infection Control – Prof Derrick Crook 23 Sept. 6pm 2a &2b post-grad centre Confirmed Dr Jane Collier, Dr Ellie Barnes, Prof Paul Klenerman Hepatitis C – Genes, screens and new vaccines. Viral Hepatitis affects 1 in 12 people in the world. … Read more
This month, ScienceWatch.com presents a listing of the top 20 institutions which, according to our Special Topic on Meningitis, attracted the highest total citations to their papers published on the topic in Thomson Reuters-indexed journals. These institutions are the top 20 ranked by total cites out of a pool of 9,661 institutions publishing on this … Read more
As part of our ongoing programme to promote and support research integrity (sometimes known as the responsible conduct of research), the University of Oxford (through its Research Services), in collaboration with the Oxford Biomedical Research Centre, have organised a further series of lunchtime seminars on a range of research integrity themes. All are welcome and … Read more
On 28th September 2010 OBN will be showcasing the latest life science spin-outs and start-ups at its first London BioTuesday, where it hopes to raise the profile of these exciting companies with a mixed audience of investors, R&D companies and other members. From stem cell technology, new monoclonal antibody therapeutics and services, pre-clinical respiratory drug discovery, novel … Read more
In 2007 the NIHR Biomedical Research Centre, Oxford was awarded £57m over five years from the National Institute of Health Research (NIHR) to carry out translational research for patient benefit. This successful bid combined the research expertise of the University of Oxford and the Oxford Radcliffe Hospitals NHS Trust to form a partnership which has … Read more
Dr Andrea Nemeth, Consultant Clinical Geneticist and Honorary Senior Lecturer at Oxford’s Churchill Hospital and the University of Oxford, is part of a team that is currently testing two next-generation sequencing platforms – the Roche 454 and Illumina systems – for use in a hospital setting. They’re benchmarking these two next-generation platforms against gold standard … Read more
Professor Russell Foster is the lead investigator of a team of researchers funded by the Oxford Biomedical Research Centre to look at sleep and circadian rhythms, and how these areas of neuroscience impact upon patient care. He has recently been appointed as the new Chair of The Times Cheltenham Science Festival. The Chair of the … Read more
Peter Brown has recently been appointed as Professor of Experimental Neurology, Department of Clinical Neurology and as an Honorary Consultant Neurologist within the Oxford Radcliffe Hospitals NHS Trust. Professor Brown was attracted from UCL in London to Oxford by the range and volume of innovative work being done here by Professor Tipu Aziz, Head of … Read more